The present invention relates to a class of compounds represented by the Formula 1.
1
or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula 1, and methods of selectively inhibiting or antagonizing the &agr;
V
&bgr;
3
and/or the &agr;
V
&bgr;
5
integrin.
本发明涉及一类由
化学式1.1表示的化合物或其药用可接受的盐,包括化合物1的制药组合物,以及选择性抑制或拮抗αVβ3和/或αVβ5整合素的方法。